Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?
Release Date:
In this week’s View, Dr. Eagle explores the associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease. He then discusses a study that looks at stroke risk in women with atrial fibrillation. Finally, Dr. Eagle examines the DCM Precision Medicine Study of rare variant genetics and dilated cardiomyopathy severity. Subscribe to Eagle’s Eye View
Eagle’s Eye View: Can apixaban be used safely in patients with AF and end-stage kidney disease?